Merck to Invest 14 Billion KRW in Korean Advanced Technology Center
Already in 2002, Merck established Merck Advanced Technology Ltd. (MAT) to consolidate all , where Merckits display business and operational activities in one location to better serve the Korean LCD manufacturersindustry were put together. AfterWith this 1st initial investment, a production and warehouse site was opened in Poseung in 2002.
“Merck’s investment in Poseung at that point in time was the right decision to serve meet the growing demands of the growing Korean LCD industry,” said Dr. Andreas Kruse, President of Merck in Korea of the market in the best way. “Close cooperation with our customers is a key To close and to cooperate with our clients are another keys to assure our successful business development. Thus, further investments in the following year and our investment decision The investment we are announcing today reconfirms Merck’s commitment to stimulate providing innovation innovative solutions to ensure thefor assuring future success of the Korean display industry.”, said Dr. Kruse, President of Merck in Korea.
In Korea, theseMerck’s close ties with customers are established throughalready apparent at MAT, which offers with offering a one-stop cooperation system to Korean LCD manufacturers. The system begins in the research and development phase and moves on to production, quality management along withand business cooperation.
MAT’s already showed its cutting-edge technologies are not just for LClimited to liquid crystals but also for include OLED (Organic Light-Emitting Diodes) technology, organic TFT (thin-flim transistors), organic solar cell, RFID (Radio Frequency Identification), optical film materials and RM (Reactive Mesogen) (RM). In 2007, Merck was awarded honored by the Ministry of Science & Technology and was granted a Prime Minister Award on the 7th Seventh Foreign Company Day in November due to for its contributions to the Korean Economy.
About Merck in Korea:
Merck Ltd., registered in 1989, and Merck Advanced Technologies Ltd., established in 2002, are the Merck companies in Korea and operate in pharmaceuticals and the chemical industries of Liquid Crystals, Performance & Life Science Chemicals like such as Pigments, Life Science products and Analytics. In 1999, Merck in Korea set up its Korean pharmaceutical operation. This was integrated with and proceeding its integration procedure of Serono Korea after Merck KGaA’s purchase of Serono S.A.in 2007.
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merck.co.kr .
Merck is a global pharmaceutical and chemical company with sales of EUR 6.3 billion in 2006, a history that began in 1668, and a future shaped by 30,962 employees in 61 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
웹사이트: http://www.merck.co.kr
연락처
Merck Ltd. Korea, Corporate Communications
Soo-Kyung Jeon ++82-2-2185-3919 / 이메일 보내기
Mira Jung ++82-2-2185-3838 / 이메일 보내기
이 보도자료는 Merck Ltd.가(이) 작성해 뉴스와이어 서비스를 통해 배포한 뉴스입니다.
-
2008년 8월 26일 08:51
-
2008년 7월 25일 09:29